Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Iveric Bio Inc (ISEE)  
$39.95 0.00 (0.00%) as of 4:30 Mon 7/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 153,922,000
Market Cap: 6.15(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $37.79 - $39.95
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 40,000 561,286
Total Sell Value $0 $0 $1,546,400 $15,378,126
Total People Sold 0 0 1 5
Total Sell Transactions 0 0 2 30
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 494
  Page 19 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-06-02 4 S $39.91 $9,095,489 I/I (227,900) 4,218,026     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-05-30 4 S $41.01 $2,945,994 D/D (71,836) 119,593     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-05-30 4 S $41.01 $5,891,989 I/I (143,672) 4,331,976     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-05-29 4 S $40.99 $9,787,879 D/D (238,787) 121,576     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-05-29 4 S $40.99 $19,575,758 I/I (477,574) 4,403,812     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-05-28 4 S $40.33 $9,234,441 D/D (228,972) 128,168     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-05-28 4 S $40.33 $18,468,882 I/I (457,944) 4,642,599     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-05-27 4 S $39.87 $3,896,774 D/D (97,737) 134,489     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-05-27 4 S $39.87 $7,793,548 I/I (195,474) 4,871,571     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-05-23 4 S $38.34 $2,919,591 D/D (76,150) 137,187     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-05-23 4 S $38.34 $5,839,182 I/I (152,300) 4,969,308     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-05-22 4 S $37.57 $1,277,380 D/D (34,000) 139,289     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-05-22 4 S $37.57 $2,554,760 I/I (68,000) 5,045,458     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2014-05-13 4 S $29.75 $14,875,000 D/D (500,000) 3,139,902     -
   Peacock Bruce CFO & CBO   •       –      –    2014-05-01 4 AS $32.06 $150,572 D/D (4,643) 0     -
   Peacock Bruce CFO & CBO   •       –      –    2014-05-01 4 OE $1.65 $7,670 D/D 4,643 4,643     -
   Patel Samir Chandrakant President   •       •      –    2014-05-01 4 AS $32.27 $464,598 D/D (14,319) 104,472     -
   Guyer David R Chief Executive Officer   •       •      –    2014-05-01 4 AS $32.01 $359,508 D/D (10,665) 11,891     -
   Peacock Bruce CFO & CBO   •       –      –    2014-04-01 4 AS $33.97 $212,099 D/D (6,191) 0     -
   Peacock Bruce CFO & CBO   •       –      –    2014-04-01 4 OE $1.65 $10,228 D/D 6,191 6,191     -
   Guyer David R Chief Executive Officer   •       •      –    2014-04-01 4 AS $34.00 $412,221 D/D (12,027) 22,556     -
   Patel Samir Chandrakant President   •       •      –    2014-04-01 4 AS $33.98 $578,376 D/D (16,876) 118,791     -
   Guyer David R Chief Executive Officer   •       •      –    2014-03-24 4 AS $34.36 $415,316 D/D (12,027) 34,583     -
   Patel Samir Chandrakant President   •       •      –    2014-03-24 4 AS $34.40 $582,915 D/D (16,876) 135,667     -
   Peacock Bruce CFO & CBO   •       –      –    2014-03-24 4 AS $34.71 $213,369 D/D (6,137) 0     -

  494 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 19 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed